Sir,
I read with interest the article of Coventry and Morton (2003) that investigated DC infiltration within breast cancers and the association with survival. Interestingly, they found that more patients were alive at the 5-year time point in the group with higher CD1a DC density than the lower CD1a DC group, but this failed to reach statistical significance at the P=0.05 level.
In our opinion, the role of CD1 family molecules in antitumour immune responses, and in particular of CD1a, should be more debated, since its expression was recently described not only in monocyte-derived dendritic cells, but also in nonmesenchymal cytotypes, that is, epithelial cells (Ulanova et al, 2000).
We recently described the immunoexpression of CD1a by metaplastic cells in a large series of Barrett's metaplasia, both gastric- and intestinal-type (Cappello et al, 2003); we found a strong expression of this marker in epithelial cells of metaplastic glands, whereas normal gastric and colonic mucosae resulted negative. This expression had a diagnostic role, as well as predict a favourable outcome, since its expression lacked when, at follow-up, the same metaplastic lesions progressed towards dysplasia or cancer.
Based on all these observations, we strongly recommend further studies on the antitumour role of CD1a and its potential role during immuno-surveillance, not only in invasive cancers but also during the carcinogenetic steps.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cappello F, Rappa F, Bucchieri F, Zummo G (2003) CD1a as a novel biomarker for the diagnosis and the clinical outcome of Barrett's metaplasia. Lancet Oncol 4: 497
Coventry BJ, Morton J (2003) CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br J Cancer 89: 533–538
Ulanova M, Torebring M, Porcelli SA, Bengtsson U, Magnusson J, Magnusson O, Lin XP, Hanson LA, Telemo E (2000) Expression of CD1d in the duodenum of patients with cow's milk hypersensitivity. Scand J Immunol 52: 609–617
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cappello, F. Is CD1a involved in antitumour immune responses during carcinogenesis?. Br J Cancer 90, 938 (2004). https://doi.org/10.1038/sj.bjc.6601597
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6601597
This article is cited by
-
CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer
British Journal of Cancer (2005)